11/09/2025

NewsFeed Voices Science Insight Innovation

11/09/2025

Sep 11, 2025, 15:42 | Insight
The True Price of Gene Therapy: Breaking Down Beqvez’s $3.5M Cost and What Really Drives It
Scott Jeffers, Chief Technology Officer at GenSight Biologics, has shared a post on LinkedIn: "The…
Sep 11, 2025, 15:31 | Organizations
WFH & EAHAD Host Regional Workshop on Shared Decision-Making in Hemophilia in Prague
The World Federation of Hemophilia (WFH) shared on LinkedIn: "This weekend, the WFH & European…
Sep 11, 2025, 15:27 | Voices
Postpartum Haemorrhage: In Kenya, More than 120 Mothers Die for Every 100,000 Live Births
Denis Brutus Oduor, Nairobi County Blood Services Coordinator, share on LinkedIn: ''Tools alone won’t save…
Sep 11, 2025, 15:11 | Voices
Join the Global Effort: World Thrombosis Day Campaign for Healthcare and Community Organizations
Louise Bannon, Director of Membership, Marketing and External Relations at ISTH, shared a post on…
Sep 11, 2025, 15:03 | Science
Rapid ADAMTS13 Assays: A Key Milestone in the 100 Years of Innvoation in TTP Diagnosis - Silvio Castagni
Silvio Castagni, Hemostasis Business Manager at Werfen, shared on LinkedIn: ''Rapid ADAMTS13 Assays: a key…
Sep 11, 2025, 14:49 | Insight
Samantha Nelson Shares "The Beat" - World Thrombosis Day Just Added Newsletter to LinkedIn
Samantha Nelson, Marketing Campaign Manager - World Thrombosis Day, ISTH, shared on LinkedIn: ''Exciting news!…
Sep 11, 2025, 14:26 | Voices
José Antonio García Erce: Self-Sufficiency in Blood Products - Utopia or Reality?
José Antonio García Erce, Director of the Donation Center, Navarre Health Service (Osasunbidea), shared on…
Sep 11, 2025, 14:25 | Science
Thrombin Generation Assays to Assess COC-Associated Procoagulant Alterations
RPTH Journal shared on LinkedIn: ''Combined oral contraception (COC) alters hemostasis in ways standard labs…
Sep 11, 2025, 13:55 | Science
Transplantation-Mediated Alloimmune Thrombocytopenia: Mostafa Faisal Mohammed Saleh Presents a Rare Case
Mostafa Faisal Mohammed Saleh, Associate professor of Clinical Hematology and HSCT at Assiut University, shared…
Sep 11, 2025, 13:37 | Drugs
Marstacimab Shows 93% Reduction in Treated Bleeds in its Phase 3 Trial
National Bleeding Disorders Foundation shared on LinkedIn: ''Promising news for the hemophilia community! Pfizer’s HYMPAVZI™…
12
All: 19 Posts: 1 - 10